ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes
Recruiting · NCT07228650 · Observational (researchers observe without assigning treatment) · Lead sponsor: King's College London
View the official record on ClinicalTrials.gov →What this trial is about
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition affecting 5.9% of young people. Late adolescence can be a particularly challenging period for young people with ADHD, with major life transitions, new demands and increased expectations. This vulnerable phase also coincides with the transition from child and adolescent mental health care to adult ADHD services, where new UK data show that most young people with ADHD do not successfully transfer to adult services. Therefore, many young people with ADHD do not receive appropriate interventions at a time when they may need them most. Opportunities for intervention are currently not fully realised due to both the young people's disengagement from clinical services and our limited understanding of real-world targets for more holistic interventions. The current study seeks to address these needs using remote (not in-person) measurement technology (RMT). The MRC-funded project, ART-transition, will use the ADHD Remote Technology ('ART') assessment and monitoring assessments with young people with a diagnosis of ADHD aged 16-17 and the RADAR-base mobile-health platform to which it is linked. ART consists of active (e.g. questionnaires) and passive (e.g. sleep) smartphone app monitoring. In the study, the investigators will address three questions on the transition to adulthood for individuals with ADHD: what changes take place, what predicts them, and how can the investigators prevent negative outcomes and support healthy lifestyles? The investigators will remotely monitor 250 young people with ADHD over two years. The investigators will then co-design, with young people with ADHD, a prototype for a new ADHD-transition smartphone app. Our approach focuses on giving young people with ADHD greater autonomy in how they manage their ADHD, in collaboration with their clinician, and places the emphasis on modifiable environmental factors and the prevention of negative outcomes.
Who can take part
Inclusion criteria
- Diagnosis of DSM-5 ADHD
- Aged 16-17
- Able to give informed consent for participation
- Willing and able to complete self-reported assessments via smartphone
- Willing to use either their own compatible Android phone or a study Android - phone as their only smartphone during the data collection period
- Willing to wear the wearable device during the data collection period
Exclusion criteria
- Psychosis, currently experiencing a major depressive episode, mania, drug dependence in the last six months, or a major neurological disorder.
- Recent contact with psychiatric acute care (admission, crisis team or liaison team (A\&E) in the last six months
- Any other major medical disease which might impact upon the patient's ability to participate in normal daily activities (e.g., due to hospitalisations)
- Pregnancy
- IQ \< 70
- Informant Inclusion Criteria:
- A parent or guardian, as chosen by the participant with ADHD
- Aged 18 or over
- Willing and able to complete web-based questionnaires regarding the participant with ADHD
Where it is running
1 location listed.
- King's College London - London, United Kingdom